Zacks Investment Research on MSN
Corcept resubmits NDA for relacorilant in Cushing's syndrome
Corcept Therapeutics CORT announced that it has resubmitted the new drug application (NDA) for its proprietary, selective ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
View Corcept Therapeutics Incorporated. CORT stock quote prices, financial information, real-time forecasts, and company news from CNN.
From assembly to comfort, we put CORT’s furniture rental service and sleeper sofa to the test Furnishing a home is no easy ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Mike Davis brings strong experience in domestic and international rental, relocation and retail services to the role, with a demonstrated ability to drive innovative strategies leading to increased ...
Corcept Therapeutics (CORT) closed the last trading session at $55.12, gaining 19% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
A high-level overview of Corcept Therapeutics Incorporated (CORT) stock. View (CORT) real-time stock price, chart, news, analysis, analyst reviews and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results